1
/
of
0
FDA Drug Approval, N011287, KAYEXALATE
FDA Drug Approval, N011287, KAYEXALATE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 011287
Company: CONCORDIA
Drug Name: KAYEXALATE
Active Ingredients: SODIUM POLYSTYRENE SULFONATE
Strength: POWDER;ORAL, RECTAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: PRIORITY
Company: CONCORDIA
Drug Name: KAYEXALATE
Active Ingredients: SODIUM POLYSTYRENE SULFONATE
Strength: POWDER;ORAL, RECTAL
Dosage Form/Route: Discontinued
Action Date: ORIG-1
Marketing Status: None
Submission Classification: PRIORITY
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details